ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Total du passif207.31 M201.23 M191.39 M188.3 M159.25 M144.93 MTotal des capitaux propres134.27 M62.42 M19.19 M13.45 M27.29 M4.41 MTotal du passif et des capitaux propres341.59 M263.65 M210.58 M201.75 M186.53 M149.34 MDette totale52.43 M49.58 M51.67 M54.07 M53.6 M47.18 MDette nette52.43 M49.58 M51.67 M54.07 M53.6 M47.18 M
Editas Medicine, Inc. - Common Stock
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.